“…S6K1 and eIF4E-binding protein (4EBP1) are the downstream factors of AKT/mTOR pathway, and its activity can be improved by folic acid in a dose-dependent manner ( Pende et al, 2004 ; Hwang et al, 2015 ). In mammalian cell models, S6K1 is a predominantly regulator of cell and body size ( Ruvinsky and Meyuhas, 2006 ; Bonucci et al, 2020 ) and phosphorylates ribosomal protein S6 kinase accelerates the protein synthesis by enhancing the translation initiation ( Wilson et al, 2009 ; Fidalgo et al, 2022 ). In the current study, although no differences were found on mRNA expression and protein abundance of AKT and S6K1 between groups, higher protein expression of p-AKT and p-S6K1 was observed in the folic acid supplementation group.…”